earnings is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Atea Pharmaceuticals, the most common co-covered peer. Each story carries 6 original sources on average, compared with 3.9 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Profound Medical
earnings is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Atea Pharmaceuticals, the most common co-covered peer. Each story carries 6 original sources on average, compared with 3.9 for the broader beat in this window. At 5, the average consequence score sits below the same-window beat average of 6.6. Profound Medical appears in 1 tracked SaaS story from March 5, 2026.
Stories tracked
1
Sources per story
6
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 35 SaaS stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Profound Medical. Shared-story counts are live from our verified record — not editorial picks.
Rumble and OptimizeRx reported their fourth-quarter and full-year 2025 financial results, highlighting significant growth in cloud infrastructure and digital health engagement. These results underscore a broader trend of resilient demand for specialized SaaS platforms and independent cloud ecosystems.